000 | 01769 a2200481 4500 | ||
---|---|---|---|
005 | 20250514071630.0 | ||
264 | 0 | _c20030702 | |
008 | 200307s 0 0 eng d | ||
022 | _a1660-2129 | ||
024 | 7 |
_a10.1159/000070815 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Hua | |
245 | 0 | 0 |
_aRole of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity to glomerular epithelial cells. _h[electronic resource] |
260 |
_bNephron. Experimental nephrology _c2003 |
||
300 |
_ae17-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCimetidine _xpharmacology |
650 | 0 | 4 |
_aCytochrome P-450 CYP2B1 _xantagonists & inhibitors |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEpithelial Cells _xdrug effects |
650 | 0 | 4 |
_aHeme Oxygenase (Decyclizing) _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrogen Peroxide _xmetabolism |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 |
_aKidney Glomerulus _xdrug effects |
650 | 0 | 4 |
_aNephrotic Syndrome _xenzymology |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aPuromycin Aminonucleoside _xadverse effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aBaliga, Mithra | |
700 | 1 | _aBigler, Steven A | |
700 | 1 | _aBaliga, Radhakrishna | |
773 | 0 |
_tNephron. Experimental nephrology _gvol. 94 _gno. 1 _gp. e17-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000070815 _zAvailable from publisher's website |
999 |
_c12590389 _d12590389 |